Bird, P., Bensen, W., El-Zorkany, B., Kaine, J., Manapat-Reyes, B. H., Pascual-Ramos, V., . . . Thirunavukkarasu, K. (2019). Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety. J Clin Rheumatol.
Citação norma ChicagoBird, Paul, et al. "Tofacitinib 5 Mg Twice Daily in Patients With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety." J Clin Rheumatol 2019.
Citação norma MLABird, Paul, et al. "Tofacitinib 5 Mg Twice Daily in Patients With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety." J Clin Rheumatol 2019.